Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease

Association of Low‐Density Lipoprotein Cholesterol Levels During Statin Treatment With Cardiovascular and Renal Outcomes in Patients With Moderate Chronic Kidney Disease

Background The benefit of low‐density lipoprotein cholesterol (LDL‐C) levels in chronic kidney disease populations remains unclear. This study evaluated the cardiovascular and renal outcomes in patients with stage 3 chronic kidney disease with different LDL‐C levels during statin treatment. Methods...

Ful tanımlama

Detaylı Bibliyografya
Asıl Yazarlar: Chieh‐Li Yen, Pei‐Chun Fan, Cheng‐Chia Lee, Jia‐Jin Chen, George Kuo, Yi‐Ran Tu, Pao‐Hsien Chu, Hsiang‐Hao Hsu, Ya‐Chung Tian, Chih‐Hsiang Chang
Materyal Türü: Makale
Dil:English
Baskı/Yayın Bilgisi: Wiley 2022-10-01
Seri Bilgileri:Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Konular:
cardiovascular disease
chronic kidney disease
low‐density lipoprotein cholesterol
statin
stroke
Online Erişim:https://www.ahajournals.org/doi/10.1161/JAHA.122.027516

Internet

https://www.ahajournals.org/doi/10.1161/JAHA.122.027516

Benzer Materyaller